peripheral embolization coils Market

The Peripheral Embolization Coils market was valued at US$ 433.06 million in 2023 and is expected to reach US$ 613.96 million by 2031. It is estimated to register a CAGR of 4.5% from 2023 to 2031.

The increasing prevalence of vascular diseases, growing aging population, technological advancements in embolization coils, and increasing research and development activities on embolization coils are key factors driving the growth of the market.

An aortic aneurysm is a bulging in the wall of the body's major artery or aorta. According to the American Heart Association's 2023 data, aortic aneurysms were the cause of 150,000 fatalities reported across the world in 2020, indicating a 26% rise from 2010. Smokers and women had greater rates of aneurysmal rupture. Currently, there are no effective medications to prevent the development of aortic aneurysms; the only treatment options are surgical or endovascular repair. Embolization agents are frequently used as substitutes for open surgeries, which are riskier and followed by longer recovery periods. Peripheral vascular embolization coils, cyanoacrylate or fibrin glue, gel foam, and Onyx are among the embolic devices that are commonly used to treat endoleaks from aortic aneurysms. Coiling is a suitable therapy option for peripheral aneurysms since it is less invasive than open surgical repair. Coils can also be used in elective settings to treat some congenital cardiac diseases, fistulas, aneurysms, and arterial side branch steal syndrome after coronary artery bypass grafting. Therefore, an upsurge in the prevalence of aortic aneurysms drives the growth of the peripheral embolization coils market. Thus, the rising prevalence of aneurysms creates a high demand for peripheral embolization coils.

By Application, Peripheral Embolization Coils Market-Based Insights

Based on application, the peripheral embolization coils market is segmented into bleedings and trauma, malformations, tumors, visceral aneurysms, endoleak type II, and varicose vein. The bleedings and trauma segment held a larger market share in 2023 and is anticipated to register a higher CAGR during the forecast period. Trauma continues to be a leading cause of death in the young population. According to an article published in BMC Public Health uncontrolled bleeding following trauma accounts for 30-40% of the total trauma-related mortality recorded across the world. As per the annual report 'Road Accidents in India-2022', in India, around 4,61,312 road accidents have been reported by States and Union Territories (UTs) during the calendar year 2022, which claimed 1,68,491 lives and caused injuries to 4,43,366 persons. This is an increase of 11.9% in accidents, 9.4% in fatalities, and 15.3% in injuries compared to 2021. The most commonly used coils for trauma embolization are micro-coils with sizes ranging from 0.038 inch to 0.035 inch and diameters ranging from 3 mm to 15 mm. Microcoils are placed through microcatheters, which typically have a lumen of 0.021 inches; the diameters of these microcatheters range from 1 mm to 20 mm. Coils can be deployed through catheters by pushing, injecting, or detaching them, with the method of detachment providing more control at the embolic site.

Based on material, the peripheral embolization coils market is segmented into platinum, platinum and hydrogel, and platinum tungsten alloy. The platinum segment held a larger market share in 2023 and is anticipated to register a higher CAGR during the forecast period.

In terms of product type, the peripheral embolization coils market is bifurcated into pushable coil and detachable coil. The detachable coil segment held a larger market share in 2023 and is anticipated to register a higher CAGR during the forecast period.

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD, Balt, Boston Scientific Corp, Wallaby Medical, Medtronic Plc, Penumbra, Inc., Cook Medical, Spartan Micro Inc., Terumo Corp, NeuroSafe Medical Co. Ltd. are among the prominent players profiled in the peripheral embolization coils market report.

Investor Presentation, World Health Organization, National Institutes of Health, Canadian Journal of Surgery, International Orthopaedic Trauma Association Supplement, German Medical Center, National Cancer Centre of Japan, are a few of the major secondary sources referred to while preparing the report on the peripheral embolization coils market.